A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSCRAIG E. HAUG, A. Benedict Cosimi, Robert B. Colvin et al.|Transplantation|1993Cited by 300
A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1William C. Goggins, A. Benedict Cosimi, Hugh Auchincloss et al.|Transplantation|2003Cited by 244
Acute Humoral Rejection in Hepatitis C‐Infected Renal Transplant Recipients Receiving Antiviral TherapySeema Baid‐Agrawal, Manuel Pascual, Nina Tolkoff‐Rubin et al.|American Journal of Transplantation|2003Cited by 136
Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory BlockadeAkira Yamada, Hugh Auchincloss, Anil Chandraker et al.|The Journal of Immunology|2001Cited by 123
CD8+ EFFECTOR CELLS RESPONDING TO RESIDUAL CLASS I ANTIGENS, WITH HELP FROM CD4+ CELLS STIMULATED INDIRECTLY, CAUSE REJECTION OF ???MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT??? SKIN GRAFTS1Richard S. Lee, Hugh Auchincloss, Michael J. Grusby et al.|Transplantation|1997Cited by 59